RhumbLine Advisers’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $20.5M | Buy |
|
|||||
|
2022
Q2 | $20.4M | Buy |
|
|||||
|
2022
Q1 | $26.1M | Sell |
|
|||||
|
2021
Q4 | $29.7M | Sell |
|
|||||
|
2021
Q3 | $27.9M | Buy |
|
|||||
|
2021
Q2 | $26.3M | Sell |
|
|||||
|
2021
Q1 | $27.2M | Sell |
|
|||||
|
2020
Q4 | $28.5M | Buy |
|
|||||
|
2020
Q3 | $24.1M | Sell |
|
|||||
|
2020
Q2 | $22M | Sell |
|
|||||
|
2020
Q1 | $13.8M | Buy |
|
|||||
|
2019
Q4 | $15.7M | Buy |
|
|||||
|
2019
Q3 | $15.4M | Buy |
|
|||||
|
2019
Q2 | $21.8M | Sell |
|
|||||
|
2019
Q1 | $25.2M | Sell |
|
|||||
|
2018
Q4 | $29.6M | Buy |
|
|||||
|
2018
Q3 | $40.7M | Buy |
|
|||||
|
2018
Q2 | $36.6M | Sell |
|
|||||
|
2018
Q1 | $28.4M | Sell |
|
|||||
|
2017
Q4 | $19.3M | Sell |
|
|||||
|
2017
Q3 | $17.6M | Buy |
|
|||||
|
2017
Q2 | $13.3M | Buy |
|
|||||
|
2017
Q1 | $11.5M | Buy |
|
|||||
|
2016
Q4 | $10.1M | Buy |
|
|||||
|
2016
Q3 | $11M | Buy |
|
|||||
|
2016
Q2 | $8.91M | Sell |
|
|||||
|
2016
Q1 | $8.08M | Buy |
|
|||||
|
2015
Q4 | $5.59M | Buy |
|
|||||
|
2015
Q3 | $5.26M | Buy |
|
|||||
|
2015
Q2 | $3.57M | Sell |
|
|||||
|
2015
Q1 | $3.94M | Buy |
|
|||||
|
2014
Q4 | $1.87M | Sell |
|
|||||
|
2014
Q3 | $1.23M | Sell |
|
|||||
|
2014
Q2 | $1.25M | Sell |
|
|||||
|
2014
Q1 | $1.31M | Sell |
|
|||||
|
2013
Q4 | $1.41M | Sell |
|
|||||
|
2013
Q3 | $1.01M | Sell |
|
|||||
|
2013
Q2 | $1.16M | Buy |
|